3 matches for your search in the start-up spotlight
rssINNOVATING DRUG DISCOVERY QGel is dedicated to making in vitro drug discovery more relevant to in vivo biology. QGel in vitro assays are physiologically relevant because they are based on clonogenically-grown cells within designer microenvironments that favour the expression of physiological ...
Following integration in January 2022, Creoptix is a Malvern Panalytical brand. Creoptix enables life scientists to accelerate discovery by providing cutting-edge tools for molecular interaction analysis, with a focus on next-generation bioanalytical instruments for drug discovery and life ...